Ligand validation:5H8Y

SRM: SIROHEME

SRM is a Ligand Of Interest in 5H8Y designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5H8Y_SRM_B_702	81%	2%	0.11	0.963	2.76	3.92	25	40	15	3	100%	1
5H8Y_SRM_A_702	81%	2%	0.115	0.968	2.9	4.01	25	44	12	3	100%	1
5H8Y_SRM_D_702	76%	2%	0.114	0.951	2.87	3.52	24	35	15	3	100%	1
5H8Y_SRM_C_702	68%	2%	0.133	0.946	3.12	3.72	23	39	9	3	100%	1
5H8V_SRM_B_702	79%	2%	0.111	0.957	2.91	4.04	21	38	10	3	100%	1
5H92_SRM_B_702	78%	5%	0.13	0.974	2.33	2.88	19	30	3	2	100%	1
3VM0_SRM_A_601	99%	26%	0.055	0.987	1.29	1.71	6	15	0	1	100%	1
7NPA_SRM_F_1109	98%	11%	0.062	0.987	2.48	1.73	20	16	2	1	100%	1
3VKT_SRM_A_601	98%	29%	0.063	0.988	1.25	1.56	6	16	0	1	100%	1
3VKS_SRM_A_601	98%	29%	0.062	0.984	1.25	1.56	7	14	0	1	100%	1
3B0G_SRM_A_601	98%	30%	0.067	0.989	1.24	1.56	7	14	0	1	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.